AMG 410 Alone and in Combination with other agents in Participants with KRAS Altered Advanced or Metastatic Solid Tumors
20240031
Phase 1 other active
Quick answer
AMG 410 Alone and in Combination with other agents in Participants with KRAS Altered Advanced or Metastatic Solid Tumors for KRAS Altered Advanced or Metastatic Solid Tumors is a Phase 1 program (other) at Amgen Technology (Ireland) UC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amgen Technology (Ireland) UC
- Indication
- KRAS Altered Advanced or Metastatic Solid Tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active